A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.

Clinical trial NCT01986114 · COMPLETED

Trial details

NCT number: NCT01986114
Sponsor: Sumitomo Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2014-01-29
Primary completion: 2018-02-08
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.